# Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome

> **NCT00348738** · PHASE3 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 300 (estimated)

## Conditions studied

- Cervix Cancer

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT00348738
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2009-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2007-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348738, "Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00348738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*